Clinical Trial Site

New Haven, Connecticut 06520

4 studies enrolling now · 12 studies all time

What they study most

Advanced Solid Cancer, Breast Cancer, Cerebral Amyloid Angiopathy, ER Positive Breast Cancer, Generalized Myasthenia Gravis, HER2 Negative Breast Carcinoma, Juvenile Myoclonic Epilepsy, KRAS G12D Mutation, Lichen Planopilaris, Locally Advanced Breast Cancer, Metastatic Breast Cancer, Prostate Cancer Metastatic

Studies at this site

• Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy — Recruiting now
• A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris — Recruiting now
• Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs) — Recruiting now
• A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma. — Recruiting now
• A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy — Starting soon
• A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation — Running, not enrolling
• A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer — Running, not enrolling
• Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer — Completed
• Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer — Completed
• Efficacy and Safety Study of WTX101 (ALXN1840) in Adult Wilson Disease Patients — Completed
• The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment — Completed